Cardene Iv Injection, Solution
Product Images NDC 43066-026

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardene Iv (NDC 43066-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cardene Structural Formula (Image 01)

Chemical structure diagram of nicardipine hydrochloride, the active ingredient in CARDENE IV injection solution. The structure includes molecular groups and indicates its chemical formula as C26H29N3O6·HCl.*

FDA Label Image

Representative 20 mg Container Lbl Panel 1 Of 2 (Image 02)

CARDENE IV 0.1 mg/mL nicardipine hydrochloride injection solution label for intravenous use, 20 mg in 200 mL (0.1 mg/mL) in a 200 mL single-dose container. The label includes dilution details, active ingredient concentration, storage instructions, manufacturer Baxter Healthcare Corporation, and safety cautions such as checking for leaks and proper disposal.*

FDA Label Image

Representative 20 mg Container Lbl Panel 2 Of 2 (Image 03)

Label panel showing a barcode placeholder with the text '*BAR CODE POSITION ONLY' and a numeric code below it. No proprietary or drug-specific information is visible in this image.*

FDA Label Image

Representative 20 mg Carton Lbl (Image 04)

The packaging label for CARDENE I.V. injection, a nicardipine hydrochloride solution in 0.86% sodium chloride. It shows a concentration of 20 mg in 200 mL (0.1 mg/mL) and indicates it is for intravenous use. The labeler is Baxter Healthcare Corporation. The label includes dosage and storage instructions, legal and patent information, and a barcode area.*

FDA Label Image

Representative Serialization 43066-026-10 (Image 05)

CARDENE IV (nicardipine hydrochloride) injection, solution 0.2 mg/mL in 200 mL (40 mg total) in 0.83% sodium chloride. Single-dose container, sterile, nonpyrogenic, iso-osmotic. Manufactured and marketed by Baxter Healthcare Corporation. Label includes dosage, storage instructions, and cautions for intravenous use.*

FDA Label Image

Representative 40 mg Container Panel 1 Of 2 (Image 06)

A small rectangular label with the text '*BAR CODE POSITION ONLY' and a numeric barcode sequence. The label is plain gray with no additional product branding or information visible.*

FDA Label Image

Representative 40 mg Container Panel 2 Of 2 (Image 07)

Packaging label for CARDENE I.V. nicardipine hydrochloride injection, solution, 0.2 mg/mL strength, provided as 40 mg in 200 mL (0.2 mg/mL). The label highlights that it is a double concentration and cautions to check infusion rate. The product contains 0.83% sodium chloride and is for intravenous use. It is manufactured and marketed by Baxter Healthcare Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.